Sildenafil citrate and fetal outcome in pregnant rats

Fetal Diagnosis and Therapy

Volumn 21, Issue 3, 2006, Pages 259-263

  Refuerzo, Jerrie S ^a,c   Sokol, Robert J ^a   Aranda, Jacob V ^a   Hallak, Mordechai ^a,b   Hotra, John W ^a   Kruger, Michael ^a   Sorokin, Yoram ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c HUTZEL HOSPITAL   (United States)

Author keywords

cGMP; Hypoxia; Maternal rats; Sildenafil citrate

Indexed keywords

CYCLIC GMP; SILDENAFIL; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY HEIGHT; BODY SIZE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; EXPOSURE; FEMALE; FETUS; FETUS BLOOD; FETUS GROWTH; FETUS OUTCOME; FETUS WEIGHT; GESTATIONAL AGE; HYPOXIA; LAPAROTOMY; MATERNAL BLOOD; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROGENY; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; ANOXIA; CYCLIC GMP; FEMALE; FETAL DEVELOPMENT; FETAL WEIGHT; GESTATIONAL AGE; PIPERAZINES; PREGNANCY; PREGNANCY COMPLICATIONS; RATS;

EID: 33645680037     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091352     Document Type: Article

References (22)

1. Zusman RM: Cardiovascular data on sildenafil citrate: Introduction. Am J Cardiol 1999;83:1C-2C.
2. Boolell M, Allen MJ, Ballard SA, et al: Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8:47-52.
3. Glossmann H, Petrischor G, Bartsch G: Molecular mechanisms of the effects of sildenafil (Viagra). Exp Gerontol 1999;34:305-318.
4. Moreland RB, Goldstein I, Traish A: Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells. Life Sci 1998;62:PL309-318.
5. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM: Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998;159:2164-2171.
6. Corbin JD, Francis SH: Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem 1999;274:13729-13732.
7. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA: Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998;338:1397-1404.
8. Fink HA, MacDonald R, Rutks IR, Nelson DB, Wilt TJ: Sildenafil for male erectile dysfunction: A systematic review and meta-analysis. Arch Intern Med 2002;162:1349-1360.
9. Lim PH, Li MK, Ng FC, et al: Clinical efficacy and safety of sildenafil citrate (Viagra) in a multi-racial population in Singapore: a retrospective study of 1,520 patients. Int J Urol 2002;9:308-315.
10. Watenabe H, Ohashi K, Takeuchi K, Yamashita K, Yokoyama T, Tran Q, Satoh H, Terada H, Ohashi H, Hayashi H: Sildenafil for primary and secondary pulmonary hypertension. Clin Pharmacol Ther 2002;71:398-402.
11. Michelis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S: Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension. Circulation 2002;105:2398-2403.
12. Prasad S, Wilkinson J, Gatzoulis M: Sildenafil in primary pulmonary hypertension. N Engl J Med 2000;343:1342.
13. Kumar S: Indian doctor in protest after using Viagra to save 'blue babies'. BMJ 2002;325:181.
14. Abrahms D, Schulze-Neick I, Magee AG: Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 2000;84:E4.
15. Laan E, Van Lunsen RHW, Everaerd W, Riley A, Scott E, Boolell M: The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women. J Women Health Gend Bas Med 2002;11:357-365.
16. Berman JR, Berman LA, Flaherty LE, Lahey N, Goldstein I: Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther 2001;27:411-420.
17. Sher G, Fisch JD: Vaginal sildenafil (Viagra): A preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod 2000;15:806-809.
18. Min K, Munarriz R, Kim NN, Goldstein I, Traish A: Effects of ovariectomy and estrogen and androgen treatment on sildenafil-mediated changes in female genital blood flow and vaginal lubrication in the animal model. Am J Obstet Gynecol 2002;187:1370-1376.
19. American College of Obstetricians and Gynecologists: Intrauterine Growth Restriction. ACOG Pract Bull 12. Washington, ACOG, 2000.
20. American College of Obstetricians and Gynecologists. Hypertension in Pregnancy: ACOG Tech Bull 219. Washington, ACOG, 1996.
21. Walker DK, Ackland MJ, James GC, et al: Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica 1999;29:297-310.
22. Hallak M, Kupsky WJ, Hotra JW, Irtenkauf SM: Fetal rat brain injury: Effect of transient maternal hypoxemia. Fetal Diagn Ther 1997;12:68-71.